Literature DB >> 7574484

The envelope of mycobacteria.

P J Brennan1, H Nikaido.   

Abstract

Mycobacteria, members of which cause tuberculosis and leprosy, produce cell walls of unusually low permeability, which contribute to their resistance to therapeutic agents. Their cell walls contain large amounts of C60-C90 fatty acids, mycolic acids, that are covalently linked to arabinogalactan. Recent studies clarified the unusual structures of arabinogalactan as well as of extractable cell wall lipids, such as trehalose-based lipooligosaccharides, phenolic glycolipids, and glycopeptidolipids. Most of the hydrocarbon chains of these lipids assemble to produce an asymmetric bilayer of exceptional thickness. Structural considerations suggest that the fluidity is exceptionally low in the innermost part of bilayer, gradually increasing toward the outer surface. Differences in mycolic acid structure may affect the fluidity and permeability of the bilayer, and may explain the different sensitivity levels of various mycobacterial species to lipophilic inhibitors. Hydrophilic nutrients and inhibitors, in contrast, traverse the cell wall presumably through channels of recently discovered porins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574484     DOI: 10.1146/annurev.bi.64.070195.000333

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  481 in total

1.  Porins in the cell wall of Mycobacterium tuberculosis.

Authors:  B Kartmann; S Stenger; M Niederweis; S Stengler
Journal:  J Bacteriol       Date:  1999-10       Impact factor: 3.490

2.  A superfamily of archaeal, bacterial, and eukaryotic proteins homologous to animal transglutaminases.

Authors:  K S Makarova; L Aravind; E V Koonin
Journal:  Protein Sci       Date:  1999-08       Impact factor: 6.725

3.  Functional domains present in the mycobacterial hemagglutinin, HBHA.

Authors:  G Delogu; M J Brennan
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

4.  Comprehensive identification of conditionally essential genes in mycobacteria.

Authors:  C M Sassetti; D H Boyd; E J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

5.  Glycopeptidolipid acetylation affects sliding motility and biofilm formation in Mycobacterium smegmatis.

Authors:  J Recht; R Kolter
Journal:  J Bacteriol       Date:  2001-10       Impact factor: 3.490

Review 6.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

7.  Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Authors:  Laeticia Alibaud; Anuradha Alahari; Xavier Trivelli; Anil K Ojha; Graham F Hatfull; Yann Guerardel; Laurent Kremer
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

8.  Structure and function of GlmU from Mycobacterium tuberculosis.

Authors:  Zhening Zhang; Esther M M Bulloch; Richard D Bunker; Edward N Baker; Christopher J Squire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

9.  The N-terminal domain of OmpATb is required for membrane translocation and pore-forming activity in mycobacteria.

Authors:  Anuradha Alahari; Nathalie Saint; Sylvie Campagna; Virginie Molle; Gérard Molle; Laurent Kremer
Journal:  J Bacteriol       Date:  2007-06-15       Impact factor: 3.490

10.  A hydrolase of trehalose dimycolate induces nutrient influx and stress sensitivity to balance intracellular growth of Mycobacterium tuberculosis.

Authors:  Yong Yang; Kathleen Kulka; Ronald C Montelaro; Todd A Reinhart; James Sissons; Alan Aderem; Anil K Ojha
Journal:  Cell Host Microbe       Date:  2014-02-12       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.